by Madaline Spencer | Jul 15, 2026
Katie Gillick, Patient Advocate at Orsini Specialty Pharmacy, discusses the importance of patient and physician communication in the care of hypoparathyroidism. Hypoparathyroidism is a rare endocrine disorder in which the parathyroid glands do not...
by Madaline Spencer | Jul 14, 2026
The US Food and Drug Administration (FDA) has approved Orca-T (Tregzi), the first regulatory T cell-based immunotherapy for improving chronic graft-versus-host disease (GVHD)-free survival in adult patients with blood cancers undergoing allogeneic hematopoietic stem...
by Madaline Spencer | Jul 14, 2026
Maria Vogiatzi, MD, Division of Endocrinology at the Children’s Hospital of Philadelphia, discusses the effect of Crenessity (crinecerfont) on bone age advancement in patients with congenital adrenal hyperplasia (CAH). CAH refers to a group of...
by Madaline Spencer | Jul 13, 2026
The US Food and Drug Administration (FDA) has granted accelerated approval to Trutakna (atacicept) for the treatment of adults with primary immunoglobulin A nephropathy (IgAN) at risk for disease progression. IgAN is due to the accumulation of IgA antibodies in the...
by Madaline Spencer | Jul 10, 2026
Kristen Rohli, PhD, Associate Director of Research at Congenital Hyperinsulinism International, discusses congenital hyperinsulinism (HI) diagnosis and management. Congenital HI is a condition caused by abnormally high levels of insulin, a hormone that...
